Patrick Burnett, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 34,500 shares at $15.05 ($519K) on 2025-07-10, disclosed to the SEC on 2025-07-14.
Scheduled sale ($519k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.05 | 23,000 | $346K | 66.6% |
| 2 | $15.07 | 5,750 | $87K | 16.7% |
| 3 | $15.07 | 5,750 | $87K | 16.7% |
| Total | $15.06 avg | 34,500 | $519K | 100% |
| Filing → |
| ARQT | SELL | 2026-08-05 | $25K | — | Filing → |
| ARQT | SELL | 2026-05-13 | $5K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $16K | — | Filing → |